Category: Synergetics USA Inc.Syndicate content

Merger & acquisition activity surges this year | The week in medtech M&A

December 17, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtech M&A explodes in 2014; Synergetics pays $14m for Sterimedix; Report: Lawyer says Guidant didn't breach deal with J&J

Medtech M&A explodes in 2014

December 15, 2014 by Brad Perriello

Medtech M&A explodes in 2014

Synergetics pays $14m for Sterimedix

December 11, 2014 by Brad Perriello

Synergetics pays nearly $14 million to acquire U.K.-based cannulae and needles maker Sterimedix, misses expectations with fiscal 1st-quarter earnings.

Synergetics pays $14m for Sterimedix

Synergetics (NSDQ:SURG) said yesterday that it acquired a U.K.-based cannulae and needles maker, Sterimedix, for $13.5 million and announced lower-than-expected earnings for its fiscal 1st quarter.

Zynex CEO clears out board | Personnel Moves

January 20, 2014 by Chris Walker

Zynex CEO Thomas Sandgaard downsizes the company's board of directors as part of a larger strategy to restructure the company.


Zynex (OTC:ZYXI) CEO Thomas Sandgaard has cleared the path to reshape the company after cutting its board in half.

Sandgaard asked for the resignations of board members Mats Wahlstrom, Mary Beth Vitale, Kevin Smith and Taylor Simonton, to add board members who share Sandgaard's vision for the rehab devices maker.

Synergetics closes Penn. facility, announces layoffs amid narrowed profits

October 3, 2013 by Arezu Sarvestani

Missouri medical device maker Synergetics reports a shrinking bottom line and employee reductions as it closes a Pennsylvania manufacturing facility.

Synergetics reports narrowed earnings, closure of Penn. facility

Synergetics (NSDQ:SURG) is closing a King of Prussia, Penn., manufacturing facility that employs 24 workers, transferring production to an office in O'Fallon, Miss.

Abbott's board approves AbbVie pharma spinout | Wall Street Beat

November 29, 2012 by MassDevice staff

Abbott's board approved the spinout of its branded pharmaceuticals division as AbbVie, planning to issue 1 AbbVie share for each ABT share. Wall Street Beat

Abbott (NYSE:ABT) said its board of directors approved the spinout of its branded pharmaceuticals business as AbbVie Inc. in which Abbott's shareholders will receive an AbbVie share for each ABT share they own.

The distribution is slated for Jan. 1, 2013, for shareholders of record as of Dec. 12, according to a press release.

Device tax spurs Hill-Rom to lay off 200 | Wall Street Beat

March 28, 2012 by MassDevice staff

Hill-Rom Holdings says it plans to lay off 200 workers, or 3% of its workforce, in part due to the looming medical device tax; also, AngioDynamics drops $5M on Microsulis; Kips Bay switches NASDAQ markets; Luna Innovations, Intuitive Surgical extend pact; Asahi Kasei begins $2B bid for Zoll; CRO Cetero files for bankruptcy after FDA probe; NASDAQ warns NeuroMetrix; the 6 players that dominate the EMR market; Intuitive Surgical, GE, Hitachi, Philips win federal contracts; plus a Funding Roundup and analysts' ups and downs. Wall Street Beat

Hill-Rom Holdings (NYSE:HRC) said it will lay off about 3% of its workforce, or roughly 200 workers, as it maneuvers to confront the medical device tax set to go into effect next year.